Aurinia Pharmaceuticals Inc (AUPH) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: $176.9M

AUPH ranks #2255 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

AUPH is a top-conviction position for Tang Capital Management LLC — at 10.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Goldman Sachs Group Inc has added to its AUPH position for two straight quarters, increasing it by $79.3M to reach $95.4M today.

Jane Street Group, LLC has trimmed its AUPH position for two straight quarters, cutting it by $19.7M while still holding $3.7M.

AUPH is up 1.5% today, and institutions have been net buyers of $176.9M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

AUPH posted net income of $314.1M over the trailing twelve months, and currently trades at a P/E of 7.2.

• Profitable — net income of $314.1M over the trailing twelve months
• Revenue grew 19.8% year over year
• Net income improved year over year, from $60.6M to $314.1M
• Generated $135.7M in positive operating cash flow
• Current ratio of 5.25x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.29x equity — within a conventional range